Finally, although in the human, Burkitt lymphoma is not normally associated with aberrant NF-κB activation, a mouse model that develops a MYC-driven, Burkitt-like disease represents a useful tool to study the mechanism of NF-κB-pathway components in tumorigenesis. Here, NFKB1 is linked to Burkitt lymphoma.